KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Total Liabilities (2016 - 2025)

Astrana Health's Total Liabilities history spans 15 years, with the latest figure at $1.7 billion for Q3 2025.

  • For Q3 2025, Total Liabilities rose 116.18% year-over-year to $1.7 billion; the TTM value through Sep 2025 reached $1.7 billion, up 116.18%, while the annual FY2024 figure was $840.7 million, 60.88% up from the prior year.
  • Total Liabilities for Q3 2025 was $1.7 billion at Astrana Health, up from $670.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.7 billion in Q3 2025 and bottomed at -$750.4 million in Q1 2025.
  • The 5-year median for Total Liabilities is $450.5 million (2022), against an average of $516.1 million.
  • The largest YoY upside for Total Liabilities was 116.18% in 2025 against a maximum downside of 196.97% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $336.4 million in 2021, then grew by 21.2% to $407.7 million in 2022, then rose by 28.19% to $522.6 million in 2023, then surged by 60.88% to $840.7 million in 2024, then surged by 100.12% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Total Liabilities are $1.7 billion (Q3 2025), $670.8 million (Q2 2025), and -$750.4 million (Q1 2025).